Health Care/Hospital

Novozymes opens online store on Alibaba

HANGZHOU, China, May 21, 2019 /PRNewswire/ -- China is a pioneer when it comes to e-commerce, and Alibaba is the country's biggest platform, offering everything from clothes, furniture, electronics to food, cars and home products. Now, for the first time, Novozymes' enzymes are available online ...

2019-05-21 21:26 3673

Inovio First to Advance Lassa Fever Candidate Vaccine Into a Clinical Trial

Subjects dosed in First-in-Human study of INO-4500 funded by the Coalition for Epidemic Preparedness Innovations Planned for emergency use as a stockpiled vaccine PLYMOUTH MEETING, Pa. and OSLO, Norway, May 21, 2019 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO), together with CEPI, ...

2019-05-21 21:00 3941

Nektium Pharma Commended by Frost & Sullivan for Introducing Zynamite®, a Novel Natural Extract with Ergogenic and Nootropic Properties

The product is a caffeine alternative and offers a range of benefits like superior mental and physical performance LONDON, May 21, 2019 /PRNewswire/ -- Based on its recent analysis of the European sports nutrition and health ingredients market, Frost & Sullivan recognisesSpain-based Nektium Phar...

2019-05-21 20:00 2454

AXA Hong Kong expands Medical Service in Greater Bay Area

HONG KONG, May 21, 2019 /PRNewswire/ -- AXA Hong Kong and University of Hong Kong-Shenzhen Hospital ("HKU-SZH") held their contract signing ceremony today, announcing HKU-SZH as the first official medical partner of "AXA Signature Network" ("the Network") in the Greater Bay Area. AXA Hong Kong's ...

2019-05-21 19:28 3983

First Sublingual Ketamine Drug for Treatment of Acute Pain to be Evaluated in End-of-Phase 2 Meeting with FDA

* Racemic sublingual ketamine, Wafermine, is the first sublingual ketamine drug seeking FDA approval for the treatment of moderate to severe acute pain * Wafermine is a Phase 2-ready drug for treatment resistant depression SINGAPORE, May 21, 2019 /PRNewswire/ -- iX Biopharma Ltd (SGX:42C) anno...

2019-05-21 18:11 11172

WuXi Biologics Signed Letter of Intent for Long-Term Vaccine Manufacturing Contract

SHANGHAI, May 21, 2019 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, today announced that it has entered into a strategic partnership L...

2019-05-21 07:30 3578
1 ... 550551552553554